Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sleep Apnea, Obstructive | 135 | 2025 | 1899 | 15.020 |
Why?
|
Continuous Positive Airway Pressure | 50 | 2024 | 580 | 6.830 |
Why?
|
Polysomnography | 102 | 2025 | 1871 | 6.370 |
Why?
|
Sleep Apnea Syndromes | 28 | 2024 | 984 | 4.360 |
Why?
|
Pharynx | 23 | 2024 | 436 | 3.520 |
Why?
|
Respiration | 32 | 2023 | 1665 | 3.130 |
Why?
|
Sleep Apnea, Central | 12 | 2023 | 88 | 2.630 |
Why?
|
Sleep | 52 | 2024 | 4819 | 2.490 |
Why?
|
Cheyne-Stokes Respiration | 8 | 2017 | 38 | 2.250 |
Why?
|
Arousal | 25 | 2025 | 1180 | 1.930 |
Why?
|
Acetazolamide | 6 | 2025 | 98 | 1.530 |
Why?
|
Muscle Hypotonia | 2 | 2022 | 166 | 1.400 |
Why?
|
Mandelic Acids | 5 | 2022 | 46 | 1.280 |
Why?
|
Tongue | 9 | 2024 | 406 | 1.260 |
Why?
|
Oxygen Inhalation Therapy | 6 | 2021 | 418 | 1.250 |
Why?
|
Sleep, REM | 8 | 2022 | 595 | 1.220 |
Why?
|
Respiratory System | 11 | 2022 | 564 | 1.220 |
Why?
|
Cross-Over Studies | 20 | 2025 | 2107 | 1.190 |
Why?
|
Pharyngeal Diseases | 2 | 2019 | 134 | 1.160 |
Why?
|
Apnea | 5 | 2011 | 195 | 0.960 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 3 | 2015 | 822 | 0.960 |
Why?
|
Osteoporotic Fractures | 4 | 2023 | 417 | 0.960 |
Why?
|
Wakefulness | 7 | 2023 | 1284 | 0.870 |
Why?
|
Carbon Dioxide | 7 | 2021 | 1148 | 0.820 |
Why?
|
Orthodontic Appliances | 2 | 2019 | 40 | 0.810 |
Why?
|
Oxygen Consumption | 6 | 2018 | 1880 | 0.810 |
Why?
|
Hypercapnia | 4 | 2021 | 259 | 0.810 |
Why?
|
Disorders of Excessive Somnolence | 2 | 2024 | 279 | 0.810 |
Why?
|
Pulmonary Ventilation | 8 | 2018 | 375 | 0.780 |
Why?
|
Facial Muscles | 1 | 2022 | 159 | 0.730 |
Why?
|
Galactosylceramidase | 2 | 2019 | 23 | 0.720 |
Why?
|
Leukodystrophy, Globoid Cell | 2 | 2019 | 38 | 0.710 |
Why?
|
Heart Failure | 11 | 2021 | 11879 | 0.710 |
Why?
|
Respiratory Mechanics | 12 | 2018 | 721 | 0.700 |
Why?
|
Respiratory Rate | 4 | 2021 | 180 | 0.700 |
Why?
|
Epiglottis | 8 | 2024 | 81 | 0.700 |
Why?
|
Airway Obstruction | 3 | 2021 | 672 | 0.690 |
Why?
|
Endoscopy | 8 | 2024 | 1854 | 0.670 |
Why?
|
Airway Resistance | 8 | 2024 | 407 | 0.650 |
Why?
|
Pituitary Gland | 10 | 2000 | 634 | 0.640 |
Why?
|
Pharyngeal Muscles | 4 | 2023 | 81 | 0.630 |
Why?
|
Humans | 199 | 2025 | 768166 | 0.610 |
Why?
|
Hypoglossal Nerve | 3 | 2024 | 110 | 0.590 |
Why?
|
Patient Compliance | 7 | 2024 | 2697 | 0.590 |
Why?
|
Middle Aged | 103 | 2025 | 223492 | 0.580 |
Why?
|
Docosahexaenoic Acids | 6 | 2024 | 914 | 0.560 |
Why?
|
Male | 142 | 2025 | 364719 | 0.560 |
Why?
|
Respiratory Function Tests | 8 | 2018 | 1695 | 0.550 |
Why?
|
Infant, Premature | 8 | 2018 | 2124 | 0.550 |
Why?
|
Adrenergic Uptake Inhibitors | 5 | 2021 | 186 | 0.540 |
Why?
|
Basal Metabolism | 1 | 2017 | 163 | 0.530 |
Why?
|
Iron | 2 | 2015 | 1813 | 0.520 |
Why?
|
Snoring | 5 | 2024 | 211 | 0.520 |
Why?
|
Female | 136 | 2025 | 397192 | 0.520 |
Why?
|
Habenula | 1 | 2015 | 39 | 0.500 |
Why?
|
Sleep Stages | 7 | 2020 | 706 | 0.490 |
Why?
|
Pre-Eclampsia | 1 | 2024 | 1255 | 0.470 |
Why?
|
Hypnotics and Sedatives | 6 | 2025 | 1191 | 0.470 |
Why?
|
Atherosclerosis | 4 | 2023 | 3433 | 0.460 |
Why?
|
Omeprazole | 1 | 2014 | 106 | 0.450 |
Why?
|
Oxygen | 11 | 2024 | 4270 | 0.450 |
Why?
|
Oxytocin | 2 | 2013 | 404 | 0.450 |
Why?
|
Models, Biological | 9 | 2018 | 9495 | 0.440 |
Why?
|
Respiratory Physiological Phenomena | 3 | 2014 | 192 | 0.440 |
Why?
|
Respiratory Insufficiency | 1 | 2022 | 1240 | 0.440 |
Why?
|
Adult | 82 | 2025 | 223646 | 0.430 |
Why?
|
Palate | 4 | 2024 | 126 | 0.430 |
Why?
|
Severity of Illness Index | 19 | 2025 | 15948 | 0.430 |
Why?
|
Hemodynamics | 2 | 2014 | 4194 | 0.430 |
Why?
|
Pregnancy Outcome | 1 | 2024 | 2972 | 0.430 |
Why?
|
Receptors, Dopamine D2 | 6 | 2011 | 471 | 0.430 |
Why?
|
Muscle, Smooth | 2 | 2014 | 931 | 0.430 |
Why?
|
Receptors, GABA-B | 2 | 2003 | 59 | 0.420 |
Why?
|
Electromyography | 9 | 2023 | 1401 | 0.420 |
Why?
|
Desipramine | 3 | 2017 | 183 | 0.400 |
Why?
|
Coronary Artery Disease | 2 | 2022 | 6568 | 0.390 |
Why?
|
GTP-Binding Protein alpha Subunits, Gs | 1 | 2013 | 194 | 0.390 |
Why?
|
Tyrosine 3-Monooxygenase | 6 | 2000 | 367 | 0.390 |
Why?
|
Supine Position | 7 | 2024 | 208 | 0.380 |
Why?
|
Heart Rate | 10 | 2024 | 4214 | 0.380 |
Why?
|
Baroreflex | 5 | 2013 | 154 | 0.380 |
Why?
|
Multivariate Analysis | 5 | 2024 | 12077 | 0.370 |
Why?
|
Mandibular Advancement | 2 | 2022 | 64 | 0.370 |
Why?
|
Iodine | 2 | 2023 | 285 | 0.360 |
Why?
|
Muscarinic Antagonists | 2 | 2021 | 136 | 0.350 |
Why?
|
Premature Birth | 5 | 2024 | 1829 | 0.350 |
Why?
|
Pulmonary Diffusing Capacity | 1 | 2010 | 93 | 0.340 |
Why?
|
Lung | 13 | 2022 | 10099 | 0.340 |
Why?
|
Drug Therapy, Combination | 5 | 2025 | 6316 | 0.340 |
Why?
|
Tyrosine | 1 | 2014 | 1427 | 0.330 |
Why?
|
Positive-Pressure Respiration | 2 | 2015 | 713 | 0.330 |
Why?
|
Parasympatholytics | 2 | 2020 | 89 | 0.330 |
Why?
|
Pulmonary Gas Exchange | 4 | 2015 | 389 | 0.330 |
Why?
|
Aged | 51 | 2025 | 171504 | 0.330 |
Why?
|
Treatment Outcome | 29 | 2025 | 65371 | 0.320 |
Why?
|
Pressure | 10 | 2019 | 1172 | 0.320 |
Why?
|
Proton Pump Inhibitors | 1 | 2014 | 552 | 0.320 |
Why?
|
Carbonic Anhydrase Inhibitors | 3 | 2014 | 92 | 0.300 |
Why?
|
Cardiovascular Diseases | 10 | 2024 | 15662 | 0.300 |
Why?
|
Double-Blind Method | 16 | 2025 | 12465 | 0.300 |
Why?
|
Diaphragm | 2 | 2022 | 357 | 0.300 |
Why?
|
Posture | 3 | 2024 | 957 | 0.300 |
Why?
|
Mouth Breathing | 2 | 2024 | 25 | 0.290 |
Why?
|
Locus Coeruleus | 3 | 2000 | 243 | 0.290 |
Why?
|
Phenotype | 12 | 2025 | 16726 | 0.280 |
Why?
|
Inhalation | 3 | 2017 | 145 | 0.280 |
Why?
|
Symporters | 2 | 2000 | 363 | 0.280 |
Why?
|
Infant, Newborn | 17 | 2024 | 26422 | 0.270 |
Why?
|
Linear Models | 6 | 2021 | 5884 | 0.270 |
Why?
|
Feedback, Physiological | 4 | 2020 | 482 | 0.260 |
Why?
|
Tidal Volume | 5 | 2017 | 518 | 0.260 |
Why?
|
Enzyme Inhibitors | 1 | 2016 | 3728 | 0.260 |
Why?
|
Logistic Models | 5 | 2024 | 13290 | 0.250 |
Why?
|
Case-Control Studies | 10 | 2024 | 22291 | 0.250 |
Why?
|
Dietary Supplements | 6 | 2024 | 3445 | 0.250 |
Why?
|
Circadian Rhythm | 1 | 2017 | 2593 | 0.240 |
Why?
|
Purinergic P2X Receptor Antagonists | 1 | 2024 | 24 | 0.240 |
Why?
|
Occlusal Splints | 2 | 2022 | 19 | 0.240 |
Why?
|
Models, Theoretical | 4 | 2017 | 3573 | 0.230 |
Why?
|
Bromocriptine | 3 | 1999 | 93 | 0.230 |
Why?
|
Inspiratory Capacity | 2 | 2021 | 35 | 0.230 |
Why?
|
Models, Cardiovascular | 1 | 2009 | 981 | 0.230 |
Why?
|
Gastric Inhibitory Polypeptide | 1 | 2024 | 69 | 0.230 |
Why?
|
Autistic Disorder | 1 | 2013 | 1240 | 0.230 |
Why?
|
Obesity | 6 | 2024 | 13090 | 0.220 |
Why?
|
Infant, Premature, Diseases | 1 | 2009 | 712 | 0.220 |
Why?
|
Nocturnal Myoclonus Syndrome | 1 | 2024 | 52 | 0.220 |
Why?
|
Lung Volume Measurements | 3 | 2021 | 381 | 0.220 |
Why?
|
Body Mass Index | 10 | 2024 | 13053 | 0.220 |
Why?
|
Plethysmography | 3 | 2018 | 172 | 0.220 |
Why?
|
Tranylcypromine | 1 | 2003 | 30 | 0.210 |
Why?
|
Overweight | 1 | 2014 | 2448 | 0.210 |
Why?
|
Hypertension | 5 | 2024 | 8616 | 0.210 |
Why?
|
Chemoreceptor Cells | 3 | 2014 | 87 | 0.210 |
Why?
|
GTP-Binding Proteins | 2 | 1997 | 948 | 0.210 |
Why?
|
Carotid Body | 3 | 2012 | 26 | 0.210 |
Why?
|
Haloperidol | 3 | 1999 | 394 | 0.200 |
Why?
|
Blood Pressure | 11 | 2024 | 8543 | 0.200 |
Why?
|
Altitude | 1 | 2023 | 163 | 0.200 |
Why?
|
Oropharynx | 2 | 2024 | 139 | 0.200 |
Why?
|
Sound | 1 | 2024 | 261 | 0.190 |
Why?
|
Patient Positioning | 2 | 2022 | 332 | 0.190 |
Why?
|
Amphetamine | 1 | 2003 | 222 | 0.190 |
Why?
|
Rats, Sprague-Dawley | 15 | 2003 | 8128 | 0.190 |
Why?
|
Functional Residual Capacity | 3 | 2017 | 70 | 0.190 |
Why?
|
Autonomic Nervous System Diseases | 2 | 2014 | 270 | 0.180 |
Why?
|
Stress, Psychological | 3 | 2003 | 4530 | 0.180 |
Why?
|
Tonsillectomy | 1 | 2024 | 281 | 0.180 |
Why?
|
Parity | 1 | 2024 | 931 | 0.180 |
Why?
|
Psychomotor Performance | 3 | 2024 | 1892 | 0.180 |
Why?
|
Autonomic Nervous System | 4 | 2013 | 707 | 0.180 |
Why?
|
Pregnant Women | 2 | 2023 | 576 | 0.170 |
Why?
|
Multiple Sclerosis | 1 | 2015 | 3250 | 0.170 |
Why?
|
Delayed-Action Preparations | 2 | 2022 | 969 | 0.170 |
Why?
|
Lung Compliance | 2 | 2018 | 207 | 0.170 |
Why?
|
Pregnancy | 16 | 2024 | 30256 | 0.170 |
Why?
|
Melanophores | 2 | 1998 | 16 | 0.170 |
Why?
|
Blood Circulation | 1 | 2020 | 248 | 0.170 |
Why?
|
Animals, Newborn | 9 | 2015 | 2678 | 0.170 |
Why?
|
Cohort Studies | 14 | 2024 | 41754 | 0.160 |
Why?
|
Protein Subunits | 1 | 2003 | 943 | 0.160 |
Why?
|
Single-Blind Method | 3 | 2018 | 1587 | 0.160 |
Why?
|
Neuroglia | 5 | 2000 | 960 | 0.160 |
Why?
|
Proteins | 1 | 2014 | 6009 | 0.160 |
Why?
|
Ferrochelatase | 1 | 2019 | 47 | 0.160 |
Why?
|
Rats | 18 | 2003 | 23760 | 0.160 |
Why?
|
Receptors, Adrenergic, alpha-1 | 1 | 1999 | 42 | 0.160 |
Why?
|
Dental Caries | 1 | 2023 | 429 | 0.160 |
Why?
|
Transcutaneous Electric Nerve Stimulation | 1 | 2021 | 169 | 0.160 |
Why?
|
Somatostatin | 2 | 2000 | 458 | 0.160 |
Why?
|
Paraventricular Hypothalamic Nucleus | 1 | 1999 | 121 | 0.150 |
Why?
|
Fetal Blood | 2 | 2022 | 1361 | 0.150 |
Why?
|
Neuropeptide Y | 2 | 1997 | 194 | 0.150 |
Why?
|
Animals | 31 | 2019 | 169246 | 0.150 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2024 | 529 | 0.150 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2000 | 1169 | 0.150 |
Why?
|
Melanocyte-Stimulating Hormones | 1 | 1998 | 25 | 0.150 |
Why?
|
Maternal Nutritional Physiological Phenomena | 1 | 2021 | 395 | 0.150 |
Why?
|
Respiratory System Abnormalities | 1 | 2019 | 67 | 0.150 |
Why?
|
Prospective Studies | 11 | 2024 | 54926 | 0.150 |
Why?
|
Palate, Soft | 1 | 2018 | 100 | 0.150 |
Why?
|
Periodicity | 2 | 2011 | 348 | 0.150 |
Why?
|
Cerebral Cortex | 1 | 2014 | 5812 | 0.150 |
Why?
|
Pituitary Gland, Posterior | 1 | 1997 | 42 | 0.140 |
Why?
|
Corticotropin-Releasing Hormone | 1 | 1999 | 361 | 0.140 |
Why?
|
Sheep | 5 | 2011 | 1451 | 0.140 |
Why?
|
4-Aminopyridine | 1 | 2017 | 81 | 0.140 |
Why?
|
Transcription, Genetic | 3 | 2000 | 7608 | 0.140 |
Why?
|
Valproic Acid | 1 | 2000 | 444 | 0.140 |
Why?
|
Nipecotic Acids | 1 | 2017 | 36 | 0.140 |
Why?
|
Ependymoma | 1 | 2000 | 328 | 0.140 |
Why?
|
Potassium Channel Blockers | 1 | 2017 | 162 | 0.140 |
Why?
|
Regression Analysis | 5 | 2019 | 6340 | 0.140 |
Why?
|
Indans | 1 | 2016 | 92 | 0.130 |
Why?
|
Intelligence | 1 | 2001 | 926 | 0.130 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2001 | 498 | 0.130 |
Why?
|
Birth Weight | 1 | 2024 | 2121 | 0.130 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 1 | 2019 | 325 | 0.130 |
Why?
|
Transgenes | 1 | 2019 | 1016 | 0.130 |
Why?
|
Iron Regulatory Protein 2 | 1 | 2015 | 43 | 0.130 |
Why?
|
Immunity | 1 | 2021 | 1003 | 0.130 |
Why?
|
Iron Regulatory Protein 1 | 1 | 2015 | 40 | 0.130 |
Why?
|
Combined Modality Therapy | 4 | 2024 | 8542 | 0.130 |
Why?
|
Axons | 5 | 2000 | 1677 | 0.120 |
Why?
|
Benzhydryl Compounds | 1 | 2022 | 944 | 0.120 |
Why?
|
Restraint, Physical | 3 | 2003 | 185 | 0.120 |
Why?
|
Recurrence | 2 | 2022 | 8509 | 0.120 |
Why?
|
Ventilator-Induced Lung Injury | 1 | 2016 | 135 | 0.120 |
Why?
|
S100 Proteins | 1 | 1995 | 216 | 0.120 |
Why?
|
Automobile Driving | 1 | 2020 | 442 | 0.120 |
Why?
|
Parietal Lobe | 1 | 2000 | 866 | 0.120 |
Why?
|
Cholinesterase Inhibitors | 1 | 2016 | 241 | 0.120 |
Why?
|
Sodium Chloride | 1 | 1997 | 584 | 0.120 |
Why?
|
Lung Diseases, Interstitial | 1 | 2023 | 940 | 0.120 |
Why?
|
Lactation | 1 | 1997 | 392 | 0.120 |
Why?
|
Transferrin | 1 | 2015 | 283 | 0.120 |
Why?
|
Diabetes, Gestational | 1 | 2024 | 1263 | 0.120 |
Why?
|
Respiration, Artificial | 2 | 2016 | 2726 | 0.110 |
Why?
|
Central Nervous System Stimulants | 1 | 2003 | 1168 | 0.110 |
Why?
|
Oscillometry | 1 | 2014 | 151 | 0.110 |
Why?
|
Dependovirus | 1 | 2019 | 720 | 0.110 |
Why?
|
Risk Factors | 10 | 2024 | 74944 | 0.110 |
Why?
|
Receptors, Transferrin | 1 | 2015 | 300 | 0.110 |
Why?
|
Hyperglycemia | 1 | 2022 | 1388 | 0.110 |
Why?
|
Bone Marrow Transplantation | 2 | 1998 | 2709 | 0.110 |
Why?
|
Genes, fos | 1 | 2013 | 176 | 0.110 |
Why?
|
Receptors, GABA-A | 1 | 1998 | 625 | 0.110 |
Why?
|
Receptors, Oxytocin | 1 | 2013 | 71 | 0.110 |
Why?
|
Guanosine 5'-O-(3-Thiotriphosphate) | 2 | 2003 | 87 | 0.110 |
Why?
|
Dopamine Antagonists | 4 | 2011 | 284 | 0.110 |
Why?
|
Body Weights and Measures | 1 | 2013 | 208 | 0.110 |
Why?
|
Point-of-Care Systems | 1 | 2022 | 1238 | 0.110 |
Why?
|
Retrospective Studies | 13 | 2024 | 81762 | 0.110 |
Why?
|
C-Reactive Protein | 2 | 2024 | 3858 | 0.100 |
Why?
|
Drug Combinations | 1 | 2019 | 2089 | 0.100 |
Why?
|
Central Nervous System Neoplasms | 1 | 2001 | 928 | 0.100 |
Why?
|
Motor Activity | 1 | 2003 | 2711 | 0.100 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2014 | 514 | 0.100 |
Why?
|
Baclofen | 2 | 2003 | 120 | 0.100 |
Why?
|
Placenta | 1 | 2021 | 1725 | 0.100 |
Why?
|
Follow-Up Studies | 8 | 2022 | 39348 | 0.100 |
Why?
|
Child Behavior | 2 | 2013 | 864 | 0.100 |
Why?
|
Signal Processing, Computer-Assisted | 2 | 2017 | 1489 | 0.100 |
Why?
|
Respiration Disorders | 1 | 2015 | 364 | 0.100 |
Why?
|
Salvage Therapy | 1 | 1998 | 1273 | 0.100 |
Why?
|
RNA, Messenger | 9 | 2003 | 12800 | 0.100 |
Why?
|
Societies, Medical | 2 | 2021 | 3968 | 0.100 |
Why?
|
Airway Management | 1 | 2015 | 326 | 0.100 |
Why?
|
Muscles | 1 | 2016 | 1582 | 0.100 |
Why?
|
Albumins | 1 | 2014 | 577 | 0.090 |
Why?
|
Heart | 2 | 2022 | 4446 | 0.090 |
Why?
|
Risk Assessment | 3 | 2023 | 24315 | 0.090 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2014 | 706 | 0.090 |
Why?
|
Pulmonary Atelectasis | 1 | 2012 | 160 | 0.090 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2012 | 241 | 0.090 |
Why?
|
Acute Coronary Syndrome | 1 | 2023 | 2194 | 0.090 |
Why?
|
Research Design | 3 | 2024 | 6211 | 0.090 |
Why?
|
In Situ Hybridization | 4 | 1999 | 1903 | 0.090 |
Why?
|
Antidepressive Agents | 1 | 2003 | 2913 | 0.090 |
Why?
|
Breath Tests | 1 | 2011 | 300 | 0.090 |
Why?
|
Nitrogen | 1 | 2011 | 345 | 0.090 |
Why?
|
Young Adult | 11 | 2024 | 60066 | 0.090 |
Why?
|
Oximetry | 3 | 2020 | 462 | 0.090 |
Why?
|
Prone Position | 1 | 2011 | 203 | 0.090 |
Why?
|
Neuronal Plasticity | 1 | 1999 | 1448 | 0.090 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 1 | 2015 | 558 | 0.090 |
Why?
|
Norepinephrine Plasma Membrane Transport Proteins | 2 | 2000 | 66 | 0.080 |
Why?
|
Receptors, Adrenergic, alpha-2 | 2 | 2000 | 69 | 0.080 |
Why?
|
Genetic Vectors | 1 | 2019 | 3402 | 0.080 |
Why?
|
Quantitative Trait Loci | 1 | 2018 | 2131 | 0.080 |
Why?
|
Aging | 4 | 2014 | 8744 | 0.080 |
Why?
|
Cognition Disorders | 2 | 2001 | 3980 | 0.080 |
Why?
|
Aged, 80 and over | 7 | 2023 | 59629 | 0.080 |
Why?
|
Oxyhemoglobins | 1 | 2010 | 213 | 0.080 |
Why?
|
Algorithms | 3 | 2021 | 14164 | 0.080 |
Why?
|
Pilot Projects | 5 | 2022 | 8741 | 0.080 |
Why?
|
Genome-Wide Association Study | 2 | 2019 | 12795 | 0.080 |
Why?
|
Pregnancy Complications | 1 | 2023 | 2973 | 0.080 |
Why?
|
Insulin Resistance | 1 | 2022 | 3986 | 0.080 |
Why?
|
Inflammation | 2 | 2021 | 10873 | 0.080 |
Why?
|
Erythrocytes | 3 | 2022 | 2418 | 0.080 |
Why?
|
Sex Characteristics | 4 | 2023 | 2650 | 0.080 |
Why?
|
Analgesics, Opioid | 1 | 2024 | 3837 | 0.080 |
Why?
|
Spleen | 1 | 2014 | 2295 | 0.080 |
Why?
|
Mice, Inbred C57BL | 3 | 2015 | 22379 | 0.070 |
Why?
|
Piperidines | 1 | 2016 | 1667 | 0.070 |
Why?
|
Models, Animal | 2 | 2011 | 2120 | 0.070 |
Why?
|
Brain Neoplasms | 2 | 2000 | 9118 | 0.070 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2013 | 709 | 0.070 |
Why?
|
Victoria | 3 | 2012 | 64 | 0.070 |
Why?
|
United States | 11 | 2024 | 73039 | 0.070 |
Why?
|
Electrooculography | 2 | 2018 | 113 | 0.070 |
Why?
|
Blood-Brain Barrier | 1 | 2014 | 1034 | 0.070 |
Why?
|
Pulmonary Alveoli | 1 | 2010 | 665 | 0.070 |
Why?
|
Pro-Opiomelanocortin | 2 | 1998 | 138 | 0.070 |
Why?
|
Diet | 2 | 2023 | 8089 | 0.070 |
Why?
|
Biological Clocks | 1 | 2009 | 321 | 0.070 |
Why?
|
Gestational Age | 3 | 2023 | 3621 | 0.070 |
Why?
|
Predictive Value of Tests | 5 | 2020 | 15454 | 0.070 |
Why?
|
Leukocytes, Mononuclear | 1 | 2013 | 1854 | 0.070 |
Why?
|
Age Factors | 8 | 2025 | 18412 | 0.070 |
Why?
|
Immunohistochemistry | 8 | 2000 | 11095 | 0.070 |
Why?
|
Accidents, Traffic | 1 | 2012 | 818 | 0.070 |
Why?
|
Gene Expression Regulation | 2 | 2003 | 11928 | 0.060 |
Why?
|
Practice Guidelines as Topic | 2 | 2020 | 7454 | 0.060 |
Why?
|
Australia | 2 | 2021 | 1265 | 0.060 |
Why?
|
Biomedical Research | 1 | 2021 | 3463 | 0.060 |
Why?
|
Sex Factors | 3 | 2025 | 10632 | 0.060 |
Why?
|
Asthma | 3 | 2013 | 6291 | 0.060 |
Why?
|
Dopamine Agonists | 2 | 1998 | 347 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2023 | 5889 | 0.060 |
Why?
|
Prognosis | 3 | 2021 | 30010 | 0.060 |
Why?
|
Veterans | 1 | 2018 | 2669 | 0.060 |
Why?
|
Bayes Theorem | 2 | 2023 | 2359 | 0.060 |
Why?
|
Sensitivity and Specificity | 3 | 2018 | 14729 | 0.060 |
Why?
|
Electroencephalography | 5 | 2018 | 6314 | 0.060 |
Why?
|
Prenatal Care | 2 | 2021 | 1162 | 0.060 |
Why?
|
Reproducibility of Results | 5 | 2023 | 20227 | 0.050 |
Why?
|
Hemoglobins | 1 | 2009 | 1531 | 0.050 |
Why?
|
Taiwan | 1 | 2025 | 521 | 0.050 |
Why?
|
Sulfur Radioisotopes | 1 | 2003 | 113 | 0.050 |
Why?
|
Dopamine | 2 | 2008 | 1592 | 0.050 |
Why?
|
Child | 9 | 2023 | 80917 | 0.050 |
Why?
|
GABA Agonists | 1 | 2003 | 106 | 0.050 |
Why?
|
Time Factors | 7 | 2021 | 40218 | 0.050 |
Why?
|
Hyperventilation | 2 | 2014 | 78 | 0.050 |
Why?
|
Cardiovascular System | 1 | 2010 | 841 | 0.050 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2015 | 2538 | 0.050 |
Why?
|
Disease Models, Animal | 3 | 2019 | 18349 | 0.050 |
Why?
|
Infant | 8 | 2021 | 36535 | 0.050 |
Why?
|
Fluorides | 1 | 2023 | 134 | 0.050 |
Why?
|
Prevalence | 2 | 2018 | 15869 | 0.050 |
Why?
|
Intensive Care Units | 1 | 2015 | 3800 | 0.050 |
Why?
|
Cluster Analysis | 2 | 2023 | 2732 | 0.050 |
Why?
|
Maximum Tolerated Dose | 1 | 2024 | 899 | 0.050 |
Why?
|
Formaldehyde | 1 | 2003 | 362 | 0.050 |
Why?
|
Brain Mapping | 1 | 1996 | 6685 | 0.050 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 1996 | 3729 | 0.050 |
Why?
|
Gene Expression | 3 | 2019 | 7598 | 0.050 |
Why?
|
Caveolin 1 | 1 | 2022 | 255 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 2 | 2022 | 20760 | 0.050 |
Why?
|
Computer Simulation | 1 | 2014 | 6283 | 0.050 |
Why?
|
Anthropometry | 2 | 2016 | 1346 | 0.050 |
Why?
|
Academies and Institutes | 1 | 2023 | 326 | 0.040 |
Why?
|
Obesity, Abdominal | 1 | 2023 | 375 | 0.040 |
Why?
|
Domperidone | 2 | 2011 | 24 | 0.040 |
Why?
|
Child Development | 1 | 2012 | 2330 | 0.040 |
Why?
|
Longitudinal Studies | 5 | 2018 | 14783 | 0.040 |
Why?
|
Feasibility Studies | 2 | 2022 | 5315 | 0.040 |
Why?
|
Rats, Inbred WKY | 1 | 2000 | 150 | 0.040 |
Why?
|
Wechsler Scales | 1 | 2000 | 256 | 0.040 |
Why?
|
Mouth | 1 | 2022 | 383 | 0.040 |
Why?
|
Quality of Life | 1 | 2001 | 13490 | 0.040 |
Why?
|
Mice | 3 | 2019 | 82029 | 0.040 |
Why?
|
Neurons | 1 | 1999 | 9514 | 0.040 |
Why?
|
Gene Order | 1 | 2019 | 166 | 0.040 |
Why?
|
RNA Probes | 1 | 1999 | 111 | 0.040 |
Why?
|
Cells, Cultured | 2 | 2013 | 19015 | 0.040 |
Why?
|
Midazolam | 1 | 2020 | 267 | 0.040 |
Why?
|
Drug Synergism | 1 | 2003 | 1760 | 0.040 |
Why?
|
Brain | 3 | 2003 | 27360 | 0.040 |
Why?
|
Analysis of Variance | 3 | 2012 | 6229 | 0.040 |
Why?
|
Body Weight | 2 | 2024 | 4627 | 0.040 |
Why?
|
Phosphatidylethanolamine N-Methyltransferase | 1 | 2018 | 19 | 0.040 |
Why?
|
Electric Stimulation Therapy | 1 | 2024 | 635 | 0.040 |
Why?
|
Prolapse | 1 | 2018 | 63 | 0.040 |
Why?
|
Transcription Factors | 1 | 2018 | 12168 | 0.040 |
Why?
|
Vimentin | 2 | 1996 | 257 | 0.040 |
Why?
|
Embryonic and Fetal Development | 2 | 1995 | 420 | 0.040 |
Why?
|
Peak Expiratory Flow Rate | 1 | 2018 | 144 | 0.040 |
Why?
|
Stroke | 1 | 2020 | 9755 | 0.040 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2000 | 619 | 0.040 |
Why?
|
Fluorescent Antibody Technique | 3 | 1997 | 2474 | 0.040 |
Why?
|
Sterol Regulatory Element Binding Protein 1 | 1 | 2018 | 135 | 0.040 |
Why?
|
Computational Biology | 1 | 2009 | 3568 | 0.040 |
Why?
|
Forced Expiratory Volume | 2 | 2013 | 1831 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 1998 | 11878 | 0.040 |
Why?
|
Glial Fibrillary Acidic Protein | 2 | 1998 | 563 | 0.030 |
Why?
|
Reaction Time | 1 | 2023 | 2101 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2000 | 13676 | 0.030 |
Why?
|
Norepinephrine | 1 | 2000 | 898 | 0.030 |
Why?
|
Exhalation | 1 | 2018 | 185 | 0.030 |
Why?
|
Base Sequence | 3 | 1997 | 12421 | 0.030 |
Why?
|
Achievement | 1 | 1998 | 288 | 0.030 |
Why?
|
Reference Values | 2 | 2016 | 4938 | 0.030 |
Why?
|
Hong Kong | 1 | 2017 | 170 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2023 | 12543 | 0.030 |
Why?
|
Neuropsychological Tests | 2 | 2001 | 7140 | 0.030 |
Why?
|
T-Lymphocytes | 1 | 2014 | 10266 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2021 | 1245 | 0.030 |
Why?
|
Carrier Proteins | 2 | 2000 | 4937 | 0.030 |
Why?
|
Autoradiography | 1 | 1997 | 727 | 0.030 |
Why?
|
Transduction, Genetic | 1 | 2019 | 899 | 0.030 |
Why?
|
Electrocardiography | 3 | 2018 | 6412 | 0.030 |
Why?
|
Thyroid Gland | 1 | 2023 | 1171 | 0.030 |
Why?
|
Calcium Channels | 2 | 1998 | 623 | 0.030 |
Why?
|
Social Adjustment | 1 | 1998 | 635 | 0.030 |
Why?
|
Connective Tissue Cells | 1 | 1995 | 50 | 0.030 |
Why?
|
Morbidity | 1 | 2021 | 1755 | 0.030 |
Why?
|
Automation | 1 | 2018 | 589 | 0.030 |
Why?
|
Rats, Wistar | 1 | 2000 | 1888 | 0.030 |
Why?
|
Interleukin-1beta | 1 | 2021 | 1027 | 0.030 |
Why?
|
Education | 1 | 1998 | 533 | 0.030 |
Why?
|
gamma-Aminobutyric Acid | 2 | 1999 | 1141 | 0.030 |
Why?
|
Species Specificity | 1 | 2000 | 2415 | 0.030 |
Why?
|
Video Recording | 1 | 2020 | 976 | 0.030 |
Why?
|
Placebo Effect | 1 | 2019 | 517 | 0.030 |
Why?
|
Differential Threshold | 1 | 2014 | 80 | 0.030 |
Why?
|
Child, Preschool | 2 | 2013 | 42669 | 0.030 |
Why?
|
Behavior, Animal | 1 | 2003 | 1862 | 0.030 |
Why?
|
Eye Movements | 1 | 2018 | 514 | 0.030 |
Why?
|
Nutritional Status | 1 | 2023 | 1628 | 0.030 |
Why?
|
Genotype | 2 | 2019 | 13045 | 0.030 |
Why?
|
Propofol | 1 | 2020 | 608 | 0.030 |
Why?
|
Nose | 1 | 2018 | 522 | 0.030 |
Why?
|
Radiotherapy | 1 | 2001 | 1502 | 0.030 |
Why?
|
Binding Sites | 1 | 2003 | 6020 | 0.030 |
Why?
|
Ion Channel Gating | 1 | 1996 | 429 | 0.030 |
Why?
|
Gene Transfer Techniques | 1 | 2019 | 1207 | 0.030 |
Why?
|
Ventilators, Mechanical | 1 | 2016 | 292 | 0.030 |
Why?
|
Fatty Acids | 1 | 2022 | 1812 | 0.030 |
Why?
|
Antigens, Neoplasm | 1 | 2021 | 1997 | 0.030 |
Why?
|
Muscle Contraction | 1 | 2018 | 1209 | 0.030 |
Why?
|
Genetic Engineering | 1 | 2019 | 936 | 0.030 |
Why?
|
Enzyme Activation | 1 | 2019 | 3590 | 0.030 |
Why?
|
Connective Tissue | 1 | 1995 | 425 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2021 | 3160 | 0.030 |
Why?
|
Vitamins | 1 | 2021 | 1638 | 0.030 |
Why?
|
ras Proteins | 1 | 2018 | 1058 | 0.030 |
Why?
|
Blood Gas Analysis | 1 | 2014 | 384 | 0.030 |
Why?
|
Pain Measurement | 1 | 2003 | 3583 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 2018 | 2862 | 0.030 |
Why?
|
California | 1 | 2016 | 1438 | 0.030 |
Why?
|
Pyrimidines | 1 | 2024 | 3048 | 0.030 |
Why?
|
Nadolol | 1 | 1992 | 29 | 0.030 |
Why?
|
Weight Loss | 1 | 2024 | 2721 | 0.020 |
Why?
|
Hyperoxia | 1 | 2014 | 261 | 0.020 |
Why?
|
Bronchoconstrictor Agents | 1 | 2012 | 77 | 0.020 |
Why?
|
Acoustics | 1 | 2013 | 244 | 0.020 |
Why?
|
Laser Therapy | 1 | 2019 | 1107 | 0.020 |
Why?
|
Incidence | 2 | 2021 | 21538 | 0.020 |
Why?
|
Trauma Severity Indices | 1 | 2013 | 479 | 0.020 |
Why?
|
Total Lung Capacity | 1 | 2012 | 148 | 0.020 |
Why?
|
Forecasting | 1 | 2021 | 2945 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2000 | 4860 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2021 | 3228 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2022 | 4786 | 0.020 |
Why?
|
Bronchoscopy | 1 | 2017 | 914 | 0.020 |
Why?
|
China | 1 | 2017 | 2395 | 0.020 |
Why?
|
Adolescent | 5 | 2023 | 89169 | 0.020 |
Why?
|
Lidocaine | 1 | 2014 | 546 | 0.020 |
Why?
|
Sympathetic Nervous System | 1 | 1994 | 521 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2017 | 2357 | 0.020 |
Why?
|
Airway Remodeling | 1 | 2012 | 133 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2020 | 10399 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 2019 | 4620 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2025 | 26379 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2021 | 4352 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2022 | 3671 | 0.020 |
Why?
|
Nerve Fibers | 1 | 1994 | 709 | 0.020 |
Why?
|
ROC Curve | 1 | 2018 | 3628 | 0.020 |
Why?
|
Photoplethysmography | 1 | 2010 | 66 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2021 | 10760 | 0.020 |
Why?
|
Feedback, Psychological | 1 | 2009 | 97 | 0.020 |
Why?
|
Reflex | 1 | 2011 | 375 | 0.020 |
Why?
|
Sudden Infant Death | 1 | 2011 | 293 | 0.020 |
Why?
|
Memory | 1 | 1998 | 2208 | 0.020 |
Why?
|
Comorbidity | 1 | 2023 | 10590 | 0.020 |
Why?
|
Spirometry | 1 | 2012 | 929 | 0.020 |
Why?
|
Trans-Activators | 1 | 2018 | 2857 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2024 | 3415 | 0.020 |
Why?
|
Health Status | 1 | 2001 | 4091 | 0.020 |
Why?
|
Visual Perception | 1 | 1996 | 1402 | 0.020 |
Why?
|
Insulin | 1 | 2022 | 6607 | 0.020 |
Why?
|
Blood Glucose | 1 | 2022 | 6430 | 0.020 |
Why?
|
Anesthetics, Local | 1 | 2014 | 1005 | 0.020 |
Why?
|
Aggression | 1 | 1992 | 750 | 0.020 |
Why?
|
Tracheostomy | 1 | 2011 | 430 | 0.020 |
Why?
|
Kinetics | 1 | 2014 | 6329 | 0.020 |
Why?
|
Anticonvulsants | 1 | 2017 | 1923 | 0.020 |
Why?
|
Emotions | 1 | 1998 | 2767 | 0.020 |
Why?
|
Self Report | 1 | 2018 | 3773 | 0.020 |
Why?
|
beta-Endorphin | 2 | 1996 | 43 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 1996 | 17622 | 0.020 |
Why?
|
Age Distribution | 1 | 2012 | 2873 | 0.020 |
Why?
|
Administration, Oral | 1 | 2013 | 4030 | 0.010 |
Why?
|
Chronic Disease | 2 | 2015 | 9384 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2017 | 4978 | 0.010 |
Why?
|
Odds Ratio | 1 | 2013 | 9669 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 16045 | 0.010 |
Why?
|
Microscopy, Fluorescence | 2 | 1996 | 2633 | 0.010 |
Why?
|
Cognition | 1 | 1996 | 7073 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 18065 | 0.010 |
Why?
|
Parasympathetic Nervous System | 1 | 1998 | 144 | 0.010 |
Why?
|
Glutamate Decarboxylase | 1 | 1998 | 239 | 0.010 |
Why?
|
Endocrine System Diseases | 1 | 1998 | 250 | 0.010 |
Why?
|
Isomerism | 1 | 1996 | 198 | 0.010 |
Why?
|
Microscopy, Video | 1 | 1996 | 241 | 0.010 |
Why?
|
Morphine | 1 | 1980 | 658 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 1998 | 2560 | 0.010 |
Why?
|
Extracellular Space | 1 | 1996 | 563 | 0.010 |
Why?
|
Central Nervous System Diseases | 1 | 1998 | 520 | 0.010 |
Why?
|
Signal Transduction | 1 | 1997 | 23645 | 0.010 |
Why?
|
Cell Size | 1 | 1995 | 626 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2000 | 4580 | 0.010 |
Why?
|
Calcium Channel Blockers | 1 | 1996 | 687 | 0.010 |
Why?
|
Astrocytes | 1 | 2000 | 1350 | 0.010 |
Why?
|
Cell Polarity | 1 | 1995 | 639 | 0.010 |
Why?
|
Mental Disorders | 1 | 1992 | 6874 | 0.010 |
Why?
|
Fibronectins | 1 | 1995 | 722 | 0.010 |
Why?
|
Hospitalization | 1 | 1992 | 10840 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1996 | 2486 | 0.010 |
Why?
|
Neoplasms, Second Primary | 1 | 1998 | 1061 | 0.010 |
Why?
|
Gastrointestinal Diseases | 1 | 1998 | 1206 | 0.010 |
Why?
|
Synapses | 1 | 1998 | 1765 | 0.000 |
Why?
|
Lung Diseases | 1 | 1998 | 1944 | 0.000 |
Why?
|
Kidney Diseases | 1 | 1998 | 2100 | 0.000 |
Why?
|
Placebos | 1 | 1992 | 1667 | 0.000 |
Why?
|
Fibroblasts | 1 | 1996 | 4176 | 0.000 |
Why?
|
Heart Diseases | 1 | 1998 | 2819 | 0.000 |
Why?
|
Calcium | 1 | 1996 | 5792 | 0.000 |
Why?
|
Psychiatric Status Rating Scales | 1 | 1992 | 6029 | 0.000 |
Why?
|
Myocardium | 1 | 1994 | 4788 | 0.000 |
Why?
|
Reticular Formation | 1 | 1980 | 60 | 0.000 |
Why?
|
Raphe Nuclei | 1 | 1980 | 104 | 0.000 |
Why?
|
Pineal Gland | 1 | 1980 | 158 | 0.000 |
Why?
|
Antipsychotic Agents | 1 | 1992 | 3081 | 0.000 |
Why?
|
Mesencephalon | 1 | 1980 | 338 | 0.000 |
Why?
|
Limbic System | 1 | 1980 | 424 | 0.000 |
Why?
|
Basal Ganglia | 1 | 1980 | 553 | 0.000 |
Why?
|
Acoustic Stimulation | 1 | 1980 | 1255 | 0.000 |
Why?
|
Hypothalamus | 1 | 1980 | 1004 | 0.000 |
Why?
|
Evoked Potentials | 1 | 1980 | 1058 | 0.000 |
Why?
|
Thalamus | 1 | 1980 | 1047 | 0.000 |
Why?
|
Photic Stimulation | 1 | 1980 | 1997 | 0.000 |
Why?
|